loading page

Minimal access left ventricular reconstruction
  • +3
  • Thasee Pillay,
  • Paulo Neves,
  • federico benetti,
  • Kevin van Bladel,
  • Andrew Wechsler,
  • Lon Annest
Thasee Pillay
BioVentrix Inc
Author Profile
Paulo Neves
Centro Hospitalar de Vila Nova de Gaia Espinho EPE
Author Profile
federico benetti
Author Profile
Kevin van Bladel
BioVentrix Inc
Author Profile
Andrew Wechsler
BioVentrix Inc
Author Profile
Lon Annest
BioVentrix Inc
Author Profile

Abstract

The Revivent TC™ TransCatheter Ventricular Enhancement System (BioVentrix Inc, San Ramon, CA, USA) is intended for use in heart failure with cardiac dysfunction a previous myocardial infarction. The resultant increased left ventricular systolic volume and discrete, contiguous, non-contractile (akinetic and/or dyskinetic) scar located in the antero-septal, apical (may extend laterally) region of the left ventricle (LV) lends itself to Revivent. The procedure, called Less Invasive Ventricular Enhancement (LIVE), consists of the implantation of a series of micro-anchors pairs in order to exclude the scarred myocardium, in order to reduce and reshape the LV. We present the procedure step-by-step, as team coordination between the cardiac surgeon and the interventional cardiologist is essential to ensure good procedural outcomes. This is a novel and new technique to address Heart Failure secondary to Myocardial Infarction.

Peer review status:ACCEPTED

27 Jun 2020Submitted to Journal of Cardiac Surgery
29 Jun 2020Submission Checks Completed
29 Jun 2020Assigned to Editor
29 Jun 2020Reviewer(s) Assigned
13 Jul 2020Review(s) Completed, Editorial Evaluation Pending
13 Jul 2020Editorial Decision: Revise Major
18 Aug 20201st Revision Received
20 Aug 2020Assigned to Editor
20 Aug 2020Submission Checks Completed
20 Aug 2020Reviewer(s) Assigned
28 Aug 2020Review(s) Completed, Editorial Evaluation Pending
28 Aug 2020Editorial Decision: Revise Major
07 Sep 20202nd Revision Received
08 Sep 2020Submission Checks Completed
08 Sep 2020Assigned to Editor
08 Sep 2020Reviewer(s) Assigned
11 Sep 2020Review(s) Completed, Editorial Evaluation Pending
11 Sep 2020Editorial Decision: Accept